Iron Saccharate (Venofer)
PreclinicalSmall molecule
Iron Saccharate (Venofer) is one of 4 small molecule programs targeting Hemodialysis. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Hemodialysis
#DrugCompanyPhaseTrials
1Eliquis
Bristol-Myers SquibbApproved
Alpha Lipoic Acid
NNational Center for Complementary and Integrative Health (NCCIH)
Phase 3
Beraprost Sodium
LLung Biotechnology PBC
Preclinical
Iron Saccharate (Venofer)
SSoroka University Medical Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Iron Saccharate (Venofer). EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SSoroka University Medical Center